Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally Beard

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Placenta|May 15, 2026
Brain and C-type natriuretic peptide are expressed by the human placenta and are not altered with preeclampsia, fetal growth restriction, or placental hypoxiaBianca R Fato, Natasha de Alwis, Sally Beard, et al.
Plos One|February 22, 2018
Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsiaTu'uhevaha J Kaitu'u-Lino, Fiona C Brownfoot, Sally Beard, et al.
Scientific Reports|May 14, 2017
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatmentNatalie J Hannan, Fiona C Brownfoot, Ping Cannon, et al.
Hypertension (Dallas, Tex. : 1979)|January 15, 2019
EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) SecretionRoxanne Hastie, Fiona C Brownfoot, Natasha Pritchard, et al.
Scientific Reports|April 6, 2023
Assessment of the tocolytic nifedipine in preclinical primary models of preterm birthBridget M Arman, Natalie K Binder, Natasha de Alwis, et al.
G3 (Bethesda, Md.)|September 25, 2013
Cell-type-specific transcriptional profiles of the dimorphic pathogen Penicillium marneffei reflect distinct reproductive, morphological, and environmental demandsShivani Pasricha, Michael Payne, David Canovas, et al.
Hypertension (Dallas, Tex. : 1979)|February 11, 2015
Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsiaKenji Onda, Stephen Tong, Anzu Nakahara, et al.
Hypertension (Dallas, Tex. : 1979)|September 2, 2015
Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin SecretionStephen Tong, Tu'uhevaha J Kaitu'u-Lino, Kenji Onda, et al.
International Journal of Molecular Sciences|July 28, 2022
Actions of Esomeprazole on the Maternal Vasculature in Lean and Obese Pregnant Mice with Impaired Nitric Oxide Synthesis: A Model of PreeclampsiaNatasha de Alwis, Natalie K Binder, Yeukai T M Mangwiro, et al.
Life Science Alliance|October 19, 2022
The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular healthNatasha de Alwis, Natalie K Binder, Sally Beard, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Placenta|May 15, 2026
Brain and C-type natriuretic peptide are expressed by the human placenta and are not altered with preeclampsia, fetal growth restriction, or placental hypoxiaBianca R Fato, Natasha de Alwis, Sally Beard, et al.
Plos One|February 22, 2018
Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsiaTu'uhevaha J Kaitu'u-Lino, Fiona C Brownfoot, Sally Beard, et al.
Scientific Reports|May 14, 2017
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatmentNatalie J Hannan, Fiona C Brownfoot, Ping Cannon, et al.
Hypertension (Dallas, Tex. : 1979)|January 15, 2019
EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) SecretionRoxanne Hastie, Fiona C Brownfoot, Natasha Pritchard, et al.
Scientific Reports|April 6, 2023
Assessment of the tocolytic nifedipine in preclinical primary models of preterm birthBridget M Arman, Natalie K Binder, Natasha de Alwis, et al.
G3 (Bethesda, Md.)|September 25, 2013
Cell-type-specific transcriptional profiles of the dimorphic pathogen Penicillium marneffei reflect distinct reproductive, morphological, and environmental demandsShivani Pasricha, Michael Payne, David Canovas, et al.
Hypertension (Dallas, Tex. : 1979)|February 11, 2015
Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsiaKenji Onda, Stephen Tong, Anzu Nakahara, et al.
Hypertension (Dallas, Tex. : 1979)|September 2, 2015
Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin SecretionStephen Tong, Tu'uhevaha J Kaitu'u-Lino, Kenji Onda, et al.
International Journal of Molecular Sciences|July 28, 2022
Actions of Esomeprazole on the Maternal Vasculature in Lean and Obese Pregnant Mice with Impaired Nitric Oxide Synthesis: A Model of PreeclampsiaNatasha de Alwis, Natalie K Binder, Yeukai T M Mangwiro, et al.
Life Science Alliance|October 19, 2022
The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular healthNatasha de Alwis, Natalie K Binder, Sally Beard, et al.
Pageof 5